Ask for alternatives. There is no one right answer and there are multiple options.

The number of women over age 70 in clinical trials (testing chemotherapy regimens) is limited. And so it is difficult to draw inferences.

The number of women over age 70 in clinical trials [testing chemotherapy regimens] is limited. And so it is difficult to draw inferences.

It's easy [for the doctor] to say something improves your survival or quality of life, but it might be that the amount it improves it is so small you may decide it is not worth doing it.

Historically, there have been some biases against older women in terms of could they tolerate the [chemotherapy] treatment and whether they would benefit from it.

We want to get the biggest names we can. We want to pack Shriver, We want our speakers to pack Shriver like that.